Literature DB >> 6521986

The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema.

R Klein, B E Klein, S E Moss, M D Davis, D L DeMets.   

Abstract

The prevalence of macular edema and its relationship to a number of risk factors were examined in a population-based study in southern Wisconsin. Macular edema was determined from its presence on stereoscopic fundus photographs or from past history as recorded and documented in clinic records and photographs. For participants whose age at diagnosis of diabetes was less than 30 years and who were taking insulin (n = 919), prevalence rates of macular edema varied from 0% in those who had diabetes less than 5 years to 29% in those whose duration of diabetes was 20 or more years. In these persons, macular edema was associated with longer duration of diabetes, presence of proteinuria, diuretic use, male gender and higher glycosylated hemoglobin. For those whose age at diagnosis was 30 years or older (n = 1121), prevalence rates of macular edema varied from 3% in those who had diabetes less than 5 years to 28% in those whose duration of diabetes was 20 or more years. In these persons, presence of macular edema was associated with longer duration of diabetes, higher systolic blood pressure, insulin use, higher glycosylated hemoglobin, and presence of proteinuria.

Entities:  

Mesh:

Year:  1984        PMID: 6521986     DOI: 10.1016/s0161-6420(84)34102-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  212 in total

1.  Plasma kallikrein and diabetic macular edema.

Authors:  Edward P Feener
Journal:  Curr Diab Rep       Date:  2010-08       Impact factor: 4.810

2.  Partial resolution of diabetic macular oedema after systemic treatment with furosemide.

Authors:  A P Ciardella
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

3.  Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study.

Authors:  A P Ciardella; J Klancnik; W Schiff; G Barile; K Langton; S Chang
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

4.  Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.

Authors:  Michael J Elman; Lloyd Paul Aiello; Roy W Beck; Neil M Bressler; Susan B Bressler; Allison R Edwards; Frederick L Ferris; Scott M Friedman; Adam R Glassman; Kellee M Miller; Ingrid U Scott; Cynthia R Stockdale; Jennifer K Sun
Journal:  Ophthalmology       Date:  2010-04-28       Impact factor: 12.079

Review 5.  How the diabetic eye loses vision.

Authors:  Jaime A Davidson; Thomas A Ciulla; Janet B McGill; Keri A Kles; Pamela W Anderson
Journal:  Endocrine       Date:  2007-09-27       Impact factor: 3.633

Review 6.  Anti-vascular endothelial growth factor therapy for diabetic macular edema.

Authors:  David S Boyer; J Jill Hopkins; Jonathan Sorof; Jason S Ehrlich
Journal:  Ther Adv Endocrinol Metab       Date:  2013-12       Impact factor: 3.565

7.  Correlation of morphological pattern of optical coherence tomography in diabetic macular edema with systemic risk factors in middle aged males.

Authors:  Sambuddha Ghosh; Preeti Bansal; Harsha Shejao; Raghuraj Hegde; Debesh Roy; Shyamapada Biswas
Journal:  Int Ophthalmol       Date:  2014-03-01       Impact factor: 2.031

8.  Extract of Litsea japonica ameliorates blood-retinal barrier breakdown in db/db mice.

Authors:  Junghyun Kim; Chan-Sik Kim; Ik Soo Lee; Yun Mi Lee; Eunjin Sohn; Kyuhyung Jo; Joo Hwan Kim; Jin Sook Kim
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

9.  Correlation of a scanning laser derived oedema index and visual function following grid laser treatment for diabetic macular oedema.

Authors:  C Hudson; J G Flanagan; G S Turner; H C Chen; L B Young; D McLeod
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

10.  Clinical and metabolic factors associated with the blood retinal barrier permeability in insulin dependent diabetes mellitus without retinopathy.

Authors:  J M Benitez del Castillo; A Castillo; P C Fernandez; J Garcia Sanchez
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.